Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2654920?pdf=render |
_version_ | 1819129590698737664 |
---|---|
author | Sonja Grosskinsky Melanie Schott Christiane Brenner Sally J Cutler Peter Kraiczy Peter F Zipfel Markus M Simon Reinhard Wallich |
author_facet | Sonja Grosskinsky Melanie Schott Christiane Brenner Sally J Cutler Peter Kraiczy Peter F Zipfel Markus M Simon Reinhard Wallich |
author_sort | Sonja Grosskinsky |
collection | DOAJ |
description | Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever. |
first_indexed | 2024-12-22T08:46:08Z |
format | Article |
id | doaj.art-1eabcba06ef24a34aed47b994fb2dcad |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-22T08:46:08Z |
publishDate | 2009-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-1eabcba06ef24a34aed47b994fb2dcad2022-12-21T18:32:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0143e485810.1371/journal.pone.0004858Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.Sonja GrosskinskyMelanie SchottChristiane BrennerSally J CutlerPeter KraiczyPeter F ZipfelMarkus M SimonReinhard WallichBorrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever.http://europepmc.org/articles/PMC2654920?pdf=render |
spellingShingle | Sonja Grosskinsky Melanie Schott Christiane Brenner Sally J Cutler Peter Kraiczy Peter F Zipfel Markus M Simon Reinhard Wallich Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS ONE |
title | Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. |
title_full | Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. |
title_fullStr | Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. |
title_full_unstemmed | Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. |
title_short | Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. |
title_sort | borrelia recurrentis employs a novel multifunctional surface protein with anti complement anti opsonic and invasive potential to escape innate immunity |
url | http://europepmc.org/articles/PMC2654920?pdf=render |
work_keys_str_mv | AT sonjagrosskinsky borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT melanieschott borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT christianebrenner borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT sallyjcutler borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT peterkraiczy borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT peterfzipfel borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT markusmsimon borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity AT reinhardwallich borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity |